Table 1: Comparison of Immunohistologic Features of NLPHL and CHL
|
|
- Matilda Boone
- 5 years ago
- Views:
Transcription
1 USCAP Hematopathology Evening Specialty Conference CASE 1: Handout Yasodha Natkunam, M.D., Ph.D. Department of Pathology Stanford University School of Medicine INTRODUCTION Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) comprises approximately 5% of Hodgkin lymphomas and exhibits distinct differences in clinical, histologic and immunophenotypic features from those of classical Hodgkin lymphoma (CHL). Investigations employing microdissection techniques and single cell polymerase chain reaction assays have shown that the atypical large cells, also known as popcorn cells or lymphocyte and histiocyte ( L&H ) cells in NLPHL are clonal B-cells. 1,2 NLPHL is recognized as an indolent, germinal center-derived B-cell lymphoma with a predisposition for local recurrence and a low rate (3-5%) of progression to diffuse large B-cell lymphoma (DLBCL) Its occurrence can be preceded by or be closely associated with florid reactive follicular hyperplasia and progressive transformation of germinal centers although it is unclear whether these should be considered precursor lesions. 7,12-16 Clinically, NLPHL occurs in young adults (median age 35 years) and affects men in 75% of cases. Over half of the patients present with early stage disease and only a small minority demonstrates systemic symptoms. The disease is often confined to peripheral nodes in the cervical, axillary, inguinal and epitrochlear regions although other nodal sites such as mesenteric lymph nodes may also be affected. Bulky disease and mediastinal widening are rare as are the involvement of other organs including spleen, bone marrow, liver, lung and the skeleton. The disease is slowly progressive with frequent relapses but it generally remains indolent and sensitive to therapy. 5,10,11 In patients presenting with early stage favorable disease the five-year overall and event-free survival approximate % for both the pediatric and adult age groups. 11 The overall mortality of patients with NLPHL is increased in comparison to the general population due primarily to the development of secondary malignancies and cardiac failure. Thus, radiation and chemotherapy of reduced intensity and monoclonal antibody therapy (Rituximab) are preferred and have been found to be efficacious in the treatment of NLPHL. 10,11,17,18 The lymph node is usually significantly enlarged, exhibits a nodular architecture and a varying number of atypical large (L&H) cells with folded or multilobated nuclei. The background is rich in reactive lymphoid cells and histiocytes; the latter may be epithelioid and occur singly, in small clusters or form granulomas. Historically, nodular or diffuse patterns of NLPHL have been described: the nodular pattern exhibits L&H cells within nodules of small non-neoplastic B-cells and the diffuse pattern is composed of L&H cells in a diffuse infiltrate of reactive T-cells. 19 The World Health Organization (WHO) requires that at least a partial nodular architecture be present for the diagnosis of NLPHL. 7 However, several variant immunoarchitectural patterns have since been recognized: serpiginous/interconnected nodular pattern, nodular with prominent extra-nodular L&H cells, nodular with T-cell-rich background, diffuse moth-eaten with B-cell-rich background as well as a mixture of these patterns. 16 The characteristic immunophenotypic profile of the large atypical cells in NLPHL in comparison to CHL is summarized in Table 1. Table 1: Comparison of Immunohistologic Features of NLPHL and CHL Marker NLPHL L&H cells CHL Hodgkin/RS cells CD45 (LCA) + - CD20 + +/- CD30 -/+ + CD EBV - + EMA + - CD57+ T-cells + -
2 NLPHL can occur simultaneously with or progress to DLBCL and their clonal relationship has been well documented in the literature. 2,8,20-25 The separation of NLPHL, particularly those with a diffuse component, from T-cell-rich B-cell lymphoma (TCRBCL) can be extremely challenging. In addition, NLPHL may also be difficult to distinguish from nodular lymphocyte-rich classical Hodgkin lymphoma (NLRCHL) and T-cell lymphomas, particularly those complicated by secondary large B-cell proliferations which are often associated with EBV. CASE PRESENTATION The case selected for presentation was seen at Stanford over a period of approximately 30 years. The initial diagnosis rendered in 1975 was based on morphologic evaluation of H&E sections. Two subsequent lymph node biopsies showed no evidence of lymphoma. This case illustrates some of the complexities involved in differentiating the histologic and immunoarchitectural features of NLPHL and the overlap of these features with classical Hodgkin lymphoma, progressive transformation of germinal centers and angioimmunoblastic and peripheral T-cell lymphomas. It is hoped that the recognition of the variant immunoarchitectural patterns and progression of NLPHL will be diagnostically useful, permit better understanding of the morphologic continuum from NLPHL to DLBCL and aid in the separation of NLPHL and its progression from their morphologic mimics. Clinical History The patient is a 61-year old man who presented with a mesenteric mass. A 5.0 cm mesenteric lymph node was excised. Approximately thirty years previously the patient had undergone a supraclavicular lymph node biopsy and the diagnosis of nodular sclerosis classical Hodgkin lymphoma ( cellular phase ) was rendered for which he received chemotherapy and subtotal lymphoid irradiation. The patient had undergone two subsequent lymph node biopsies at 4 and 13 years after his initial treatment. Both of those biopsies had shown reactive follicular hyperplasia with progressive transformation of germinal centers. Histologic Features The lymph node biopsies from 1975, 1979, 1988 and 2003 have been reviewed and the salient findings are described below: 1975 Right supraclavicular lymph node: Sections show a moderately enlarged lymph node with a nodular architecture without dense sclerotic bands. The nodules are composed of a mixed background rich in small lymphocytes, histiocytes and plasma cells within which are variable numbers of atypical large cells. These large cells show binucleation and prominent nucleoli typical of Reed-Stenberg (RS) cells and mononuclear variants of RS cells. The morphologic findings are compatible with classical Hodgkin lymphoma. The spleen was also involved at laparotomy (Stage IIISA) and 1988 Right and left inguinal lymph nodes: Sections of both inguinal lymph nodes show enlargement and involvement by an exuberant reactive follicular hyperplasia. Occasional follicles are markedly enlarged, have disrupted germinal centers and are infiltrated by small lymphocytes a pattern typical of progressive transformation of germinal centers. These nodules did not exhibit Hodgkin/RS cells or L&H cells Mesenteric lymph node: Sections of the mesenteric lymph nodes show massive enlargement and effacement of the normal nodal architecture by a mottled diffuse and partially nodular atypical lymphoid proliferation. The large nodules are filled with an infiltrate of small lymphocytes admixed with epithelioid histiocytes and are studded with atypical large cells exhibiting an open, vesicular chromatin pattern and prominent single or multiple nucleoli. Rare large cells showed morphologic features of classical Hodgkin cells. The atypical large cells were also present outside lymphoid nodules. In the mottled areas, these atypical large cells formed clusters whilst focally there were sheets of atypical large cells with numerous mitotic figures and karyorrhectic debris.
3 Immunohistologic Features No immunohistologic studies were performed on the biopsies from 1975, 1979 and At the time of the 2003 review a CD20 stain was performed on the 1975 case; the large cells were positive for CD20 indicating that the original diagnosis was most likely NLPHL and not classical Hodgkin lymphoma. Immunohistologic features of the mesenteric lymph node biopsy from 2003 are summarized in Table 2. Table2: Immunohistologic Features of the Mesenteric Lymph Node Biopsy Immunostain L&H cells Description CD20 Positive Nodular areas: nodules rich in B-cells with scattered large atypical cells within and outside the nodules Mottled areas: scattered large atypical cells surrounded by CD20- negative small cells Diffuse areas: sheets of large atypical cells CD3 Negative Nodular areas: few cells within nodules Mottled areas: majority of small cells and particularly those surrounding large atypical cells (ringing or rosetting pattern) Diffuse areas: majority of small T-cells CD30 Negative Occasional scattered cells CD15 Negative Occasional scattered cells CD57 Negative Highlight cells ringing large atypical cells EMA Positive Highlight large atypical cells (similar distribution to CD20) PAX5 Positive Highlight large atypical cells (similar distribution to CD20) EBV in situ Negative CD45 Positive Highlight small lymphoid cells in nodular and diffuse areas and large atypical cells CD21 Negative Nodular areas: intact follicular dendritic cell (FDC) meshworks Mottled areas: disruption or lack of FDC meshworks Diffuse areas: scattered FDCs only Differential Diagnosis Progressive transformation of germinal centers Nodular lymphocyte-rich classical Hodgkin lymphoma Angioimmunoblastic T cell lymphoma Peripheral T-cell lymphoma complicated by a proliferation of large B-cells (B cell-rich T cell lymphoma) Nodular lymphocyte predominant Hodgkin lymphoma with progression to T cell-rich diffuse large B-cell lymphoma Final Diagnosis Nodular lymphocyte predominant Hodgkin lymphoma with progression to T cell-rich diffuse large B-cell lymphoma Clinical Follow-Up The initial diagnosis of classical Hodgkin lymphoma was based on the histologic findings on the right supraclavicular lymph node biopsy as well as the clinical presentation. The patient had multiple sites of involvement including the spleen; an intravenous pyelogram had also shown displacement of the right kidney from presumed para-aortic disease. He was treated with MOPP chemotherapy and subtotal lymphoid irradiation and was without disease for approximately 30 years, although he was at risk for developing a secondary malignancy, particularly a non-hodgkin lymphoma from his prior subtotal lymphoid irradiation. At presentation in 2003, he was diagnosed with NLPHL with progression to TCRBCL. He had high risk disease based on the International Prognostic Index (IPI) and was treated with
4 RCHOP followed by consolidative high dose chemotherapy with stem cell transplantation. He developed cardiomyopathy as a complication (probably due to subtotal irradiation as well as transplantation) but has remained in complete remission since DISCUSSION The diagnosis of NLPHL can be made challenging by several factors: its intricate immunoarchitectural patterns, its co-existence with florid follicular hyperplasia and progressive transformation of germinal centers, its progression to T-cell rich B-cell lymphoma and diffuse large B-cell lymphoma both of which may be focal and subtle, and its overlap with the histologic and immunophenotypic characteristics of classical Hodgkin and T-cell lymphomas. The morphologic and immunophenotypic features of each entity listed in the differential diagnosis are discussed below in the context of the index case. Progressive transformation of germinal centers (PTGC) 12-14,26-33 Follicular structures several times larger than typically seen in reactive follicular hyperplasia Follicles composed of mantle zone B-cells with significant numbers of CD4 T-cells that often coexpress CD57 Variably sized clusters of residual germinal center cells without the presence of the L&H cells of NLPHL Typically occurs in isolated follicles in a background of reactive follicular hyperplasia although PTGC may be more frequent in young males Most frequently presents as an incidental finding (about 5% of reactive lymph nodes) may precede, occur simultaneously or follow a diagnosis of NLPHL Table 3: Comparison of Histologic and Immunohistologic Features of PTGC and NLPHL PTGC NLPHL Low power Single large follicle Multiple large nodules (mass lesion) High power Clusters of germinal center cells (can be highlighted by CD10, BCL6 or Rare germinal centers in the nodules in 15% of cases Ki-67) CD20, CD79a, or No L&H/ popcorn cells L&H/ popcorn cells PAX5 CD3 and CD57 No ringing of L&H cells but occasional macrophages may be ringed by T-cells Ringing of L&H/ popcorn cells by T-cells The index case showed multiple enlarged B-cell rich nodules studded with L&H cells highlighted by CD20 and ringed by CD57+ and CD3+ T-cells. In addition, there were mottled and diffuse areas with CD20+ large cells in a background rich in small T-cells. These features do not support PTGC as a diagnostic consideration. However, the two prior inguinal lymph node biopsies excised in 1979 and 1988 showed reactive follicular hyperplasia with features typical of progressive transformation of germinal centers. Nodular Lymphocyte Rich Classical Hodgkin Lymphoma (NLRCHL) 6,7,34 Comprise 5% of Hodgkin lymphoma (approximately the same frequency as NLPHL) with a higher median age and a male predominance (also similar to NLPHL) Nodular or less commonly diffuse infiltrate of small lymphocytes with an absence of eosinophils and neutrophils May have regressed germinal centers within nodules Small lymphocytes within nodules are mantle-zone lymphocytes (IgM+IgD+)
5 A relatively uniform population of binucleate classic Reed-Sternberg cells and their mononuclear counterparts both of which usually have prominent eosinophilic nucleoli similar to other subtypes of CHL Immunophenotype of the atypical large cells is similar to other subtypes of CHL: they express CD30, are usually also positive for CD15 and PAX5 with a subset expressing CD20. They lack expression of CD45 (LCA) and T-cell associated markers Up to 40% of CHL have EBV-positive Hodgkin cells The low power architecture of a lymph node involved by NLPHL and NLRCHL demonstrate several similarities that include a nodular architecture usually devoid of sclerotic bands (typical of nodular sclerosis Hodgkin lymphoma), eosinophils and neutrophils. The cell composition of the nodules is predominated by small B cells and scattered atypical large cells. The Hodgkin/RS cells however differ from L&H cells in their immunophenotype (please see Table 1 for comparison of immunohistologic features of NLPHL and CHL). The index case showed CD20+ and CD45+ large atypical cells morphologically typical of L&H cells. These cells were ringed by CD57+ CD3+ T-cells and lacked staining for CD30 and CD15. In addition, the mottled and diffuse areas with increased small T-cells and CD20+ large cells (indicative of progression), is not compatible with a diagnosis of classical Hodgkin lymphoma. Angioimmunoblastic T-cell Lymphoma (AITL) Effacement of lymph node architecture by a diffuse or paracortical expansion of immunoblasts, vascular proliferation and admixed eosinophils and plasma cells Expansion of extrafollicular CD21-positive FDC meshworks CXCL13+ and CD10+ T-cells away from follicles Clonal T cell receptor gene rearrangements Associated with EBV in 50% of cases Clonal B-cell proliferations found in 35% of patients Table 4: Comparison of Histologic and Immunohistologic Features of AITL and NLPHL Low power High power CD20, CD79a, or PAX5 AITL Nodular or diffuse paracortical proliferation Immunoblastic proliferation associated with prominent vasculature and admixed eosinophils and plasma cells No L&H/ popcorn cells An associated proliferation of large B- cell may be present singly, in small clusters or as sheets of B-cells NLPHL Multiple large nodules (mass lesion) Nodules rich in small B-cells L&H/ popcorn cells Progression to T-cell rich or conventional diffuse large B-cell lymphoma may exhibit scattered or sheets-like proliferation of large B-cells CD3 Predominance of T-cells Paucity of T-cells within nodules although with increased diffuse areas the is a concomitant increase in reactive T-cells in the background CD21 EBV Extrafollicular expansions of follicular dendritic cell meshworks EBV-associated B-cell proliferations in up to 50% of cases Typically intact FDC meshworks are confined to follicles although with progression to DLBCL disrupted and absence of meshworks may be present Negative (very rare positive cases have been reported) The nodular proliferation with mottled and diffuse areas seen in the index case may be simulated by AITL, particularly an AITL complicated by a large B-cell proliferation. Both exhibit areas with scattered or clustered atypical large B-cells. However, the paracortical immunoblastic T-cell proliferation admixed with a mixed inflammatory background (eosinophils and plasma cells) together with the prominent vascular proliferation and extrafollicular dendritic cells are not characteristic of NLPHL. The lack of
6 immunostaining for CXCL13 and CD10 on extrafollicular T-cells also exclude AITL as a diagnostic possibility. In addition, T-cell receptor gene rearrangement studies may be used to confirm a clonal T-cell proliferation in cases of AITL. In cases of AITL complicated by a secondary large B-cell proliferation, EBV in situ hybridization studies typically highlight the atypical large B-cells. Clonal studies for the B-cell antigen receptor (IgH VDJ gene rearrangements) may show a polyclonal, oligoclonal or clonal pattern. EBV expression is extremely rare in cases of NLPHL. Peripheral T-cell lymphoma complicated by a proliferation of large B-cells (B cell-rich T cell lymphoma) 43,46,47 Effacement of lymph node architecture by a diffuse or paracortical expansion of atypical T-cells admixed with eosinophils and plasma cells T-cells may have clear cytoplasm and exhibit prominent vasculature Clonal T cell receptor gene rearrangements Associated with EBV in 57% of cases Clonal B-cell proliferations found in 35% of patients This is a relatively newly recognized entity in which a peripheral T-cell lymphoma is found in close association with an EBV-positive large B-cell proliferation. Similar to AITL it may simulate NLPHL particular one that shows progression to TCRBCL. However, in contrast to AITL no extrafollicular dendritic cells are present. Immunophenotypic and molecular studies (see Table 4), similar to those employed in the separation of AITL from NLPHL (with the exceptions of CD21, CXCL13 and CD10 to demonstrate extrafollicular dendritic and germinal center T-cells) are useful to distinguish this entity from NLPHL with progression to TCRBCL. Nodular Lymphocyte Predominant Hodgkin Lymphoma with progression to T-cell rich diffuse large B-cell lymphoma (NLPHL with progression to TCRBCL) Traditionally, NLPHL has been described as having a nodular growth pattern with or without a diffuse component. In a study of 137 biopsies from 118 patients we previously described six distinct immunoarchitectural patterns of NLPHL (Table 5). 16 A combination of two or more patterns was more common than a pure pattern. The presence of a diffuse pattern was more common in patients with recurrent disease and tended to be associated with progression to an increasingly more diffuse pattern over time. Sequential biopsies also showed that those with increased extranodular L&H cells were more likely to progress to TCRLBCL. Small germinal centers and prominent sclerosis, two features previously associated with CHL, were found in 15% and 20% of NLPHL cases respectively, emphasizing that these features cannot be reliably used to distinguish NLPHL from CHL. 16 The recognition of these immunoarchitectural patterns as features of NLPHL is important for its accurate diagnosis and for separation of NLPHL from CHL and TCRBCL. Table 5: Immunoarchitectural Patterns of NLPHL 16 Pattern Architecture L&H cells FDC meshworks 1. Classical nodular pattern, B-cell-rich 2. Serpiginous/interconn ected nodular pattern 3. Nodular with prominent extranodular L&H cells 4. Nodular with T-cellrich background 5. Diffuse pattern (Tcell-rich B-cell Nodules with predominance of small B-cells Misshapen nodules rich in small B-cells Background rich in reactive T-cells Nodules with increased T- cells Indistinguishable from TCRBCL (requires nodular Largely confined to nodules and ringed by CD57+ T-cells Largely confined to nodules and ringed by CD57+ T-cells Extend outside nodules and lack ringing Confined to nodules and ringed by CD57+ T-cells Lack ringing Prominent FDC meshworks Associated with FDC meshworks Lack FDC meshworks Associated with FDC meshworks Lack FDC meshworks
7 lymphoma-like) 6. Diffuse, moth-eaten with B-cell-rich background component elsewhere for diagnosis) No distinct nodular architecture but has a B-cell rich background L&H cells are ringed by CD57+ T-cells appear moth eaten on CD20 stain Associated with FDC meshworks The immunoarchitectural pattern in the index case reflects a combination of the classical nodular pattern in some areas whilst other areas show a diffuse TCRBCL-like as well as a mottled or moth-eaten pattern. The extent of the nodular areas was variable and represented 10-80% in different sections examined. Typical L&H cells were highlighted by the immunostain for CD20 and were present within and outside nodules. They were surrounded by CD57+ T-cells is the nodular areas where intact FDC meshworks were present (CD21 immunostain). However, in the mottled areas FDC meshworks were disrupted, the background had increased numbers of T-cells and the L&H cells lacked ringing by CD57+ T-cells. The presence of a diffuse pattern together with L&H cells outside nodules were found to be associated with progression of disease in our prior study: these features were evident in this case. The lack of staining of the atypical cells for CD30 and CD15 together with the areas of TCRBCL-like pattern made the diagnosis of CHL unlikely. The lack of an atypical paracortical T-cell proliferation and prominent vasculature make the diagnosis of a T-cell lymphoma less compelling. The TCRBCL-like component seen in some areas of this case may however mimic secondary EBV-associated large B-cell proliferations arising in the setting of AITL and PTCL. The immunoarchitectural features of this case captures the morphologic continuum between NLPHL and DLBCL and illustrates the complexity and overlap it shares with CHL and TCRBCL on one hand and with AITL and PTCL complicated by large B-cell proliferations on the other. Additionally, the presentation with NLPHL in this patient was preceded by PTGC on two prior lymph node excisions and occurred as a therapy-related secondary malignancy approximately 30-years after the diagnosis and treatment for presumed classical Hodgkin lymphoma. TAKE HOME LESSONS If the lymph node architecture shows mixed nodular and diffuse areas look for the presence and the distribution of atypical large cells and the company they keep In an indolent lymphoma, look for an aggressive component A relatively short panel of immunohistologic markers (CD20, CD30, CD15, PAX5, CD45, EBV ) can be employed successfully to distinguish subtypes of Hodgkin lymphoma A follicular dendritic cell marker (e.g. CD21) can be very useful to highlight a nodular architecture
8 REFERENCES 1. Marafioti T, Hummel M, Anagnostopoulos I, et al. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med. 1997;337: Ohno T, Stribley JA, Wu G, Hinrichs SH, Weisenburger DD, Chan WC. Clonality in nodular lymphocyte-predominant Hodgkin's disease. N Engl J Med. 1997;337: Miettinen M, Franssila KO, Saxen E. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-hodgkin's lymphomas. Cancer. 1983;51: Hansmann ML, Stein H, Fellbaum C, Hui PK, Parwaresch MR, Lennert K. Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol. 1989;20: Diehl V, Sextro M, Franklin J, et al. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J Clin Oncol. 1999;17: Anagnostopoulos I, Hansmann ML, Franssila K, et al. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood. 2000;96: Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumors of the hematopoietic and lymphoid tissues. Lyon: IARC Press; Rudiger T, Gascoyne RD, Jaffe ES, et al. Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol. 2002;13 Suppl 1: Boudova L, Torlakovic E, Delabie J, et al. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood. 2003;102: Jost LM, Stahel RA. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease. Ann Oncol. 2005;16 Suppl 1:i Nogova L, Rudiger T, Engert A. Biology, clinical course and management of nodular lymphocytepredominant hodgkin lymphoma. Hematology Am Soc Hematol Educ Program. 2006: Poppema S, Kaiserling E, Lennert K. Nodular paragranuloma and progressively transformed germinal centers. Ultrastructural and immunohistologic findings. Virchows Arch B Cell Pathol Incl Mol Pathol. 1979;31: Burns BF, Colby TV, Dorfman RF. Differential diagnostic features of nodular L & H Hodgkin's disease, including progressive transformation of germinal centers. Am J Surg Pathol. 1984;8: Nguyen PL, Ferry JA, Harris NL. Progressive transformation of germinal centers and nodular lymphocyte predominance Hodgkin's disease: a comparative immunohistochemical study. Am J Surg Pathol. 1999;23: Nicholas DS, Harris S, Wright DH. Lymphocyte predominance Hodgkin's disease--an immunohistochemical study. Histopathology. 1990;16: Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA. Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol. 2003;27: Ekstrand BC, Lucas JB, Horwitz SM, et al. Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial. Blood. 2003;101: Natkunam Y, Stanton TS, Warnke RA, Horning SJ. Durable remission in recurrent T-cell-rich B- cell lymphoma with the anti-cd20 antibody rituximab. Clin Lymphoma. 2001;2: Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966;26: Sundeen JT, Cossman J, Jaffe ES. Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma". Histological progression or composite malignancy? Am J Surg Pathol. 1988;12:
9 21. Grossman DM, Hanson CA, Schnitzer B. Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma. Am J Surg Pathol. 1991;15: Wickert RS, Weisenburger DD, Tierens A, Greiner TC, Chan WC. Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage. Blood. 1995;86: De Jong D, Van Gorp J, Sie-Go D, Van Heerde P. T-cell rich b-cell non-hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance hodgkin's disease. Histopathology. 1996;28: Greiner TC, Gascoyne RD, Anderson ME, et al. Nodular lymphocyte-predominant Hodgkin's disease associated with large-cell lymphoma: analysis of Ig gene rearrangements by V-J polymerase chain reaction. Blood. 1996;88: Chan WC. T-cell-rich B-cell lymphoma: what is new? What is cool? Am J Clin Pathol. 1997;108: Chang CC, Osipov V, Wheaton S, Tripp S, Perkins SL. Follicular hyperplasia, follicular lysis, and progressive transformation of germinal centers. A sequential spectrum of morphologic evolution in lymphoid hyperplasia. Am J Clin Pathol. 2003;120: Ferry JA, Zukerberg LR, Harris NL. Florid progressive transformation of germinal centers. A syndrome affecting young men, without early progression to nodular lymphocyte predominance Hodgkin's disease. Am J Surg Pathol. 1992;16: Hansmann ML, Fellbaum C, Hui PK, Moubayed P. Progressive transformation of germinal centers with and without association to Hodgkin's disease. Am J Clin Pathol. 1990;93: Jones D. Dismantling the germinal center: comparing the processes of transformation, regression, and fragmentation of the lymphoid follicle. Adv Anat Pathol. 2002;9: Kojima M, Nakamura S, Motoori T, et al. Progressive transformation of germinal centers: a clinicopathological study of 42 Japanese patients. Int J Surg Pathol. 2003;11: Osborne BM, Butler JJ. Clinical implications of progressive transformation of germinal centers. Am J Surg Pathol. 1984;8: Osborne BM, Butler JJ, Gresik MV. Progressive transformation of germinal centers: comparison of 23 pediatric patients to the adult population. Mod Pathol. 1992;5: Poppema S, Kaiserling E, Lennert K. Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres--a cytohistological study. Histopathology. 1979;3: Ashton-Key M, Thorpe PA, Allen JP, Isaacson PG. Follicular Hodgkin's disease. Am J Surg Pathol. 1995;19: Attygalle A, Al-Jehani R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood. 2002;99: Dogan A, Attygalle AD, Kyriakou C. Angioimmunoblastic T-cell lymphoma. Br J Haematol. 2003;121: Grogg KL, Attygale AD, Macon WR, Remstein ED, Kurtin PJ, Dogan A. Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol. 2006;19: Grogg KL, Attygalle AD, Macon WR, Remstein ED, Kurtin PJ, Dogan A. Angioimmunoblastic T- cell lymphoma: a neoplasm of germinal-center T-helper cells? Blood. 2005;106: Jones D, Jorgensen JL, Shahsafaei A, Dorfman DM. Characteristic proliferations of reticular and dendritic cells in angioimmunoblastic lymphoma. Am J Surg Pathol. 1998;22: Ree HJ, Kadin ME, Kikuchi M, et al. Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers. Am J Surg Pathol. 1998;22: Abruzzo LV, Schmidt K, Weiss LM, et al. B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus. Blood. 1993;82: Lome-Maldonado C, Canioni D, Hermine O, et al. Angio-immunoblastic T cell lymphoma (AILD- TL) rich in large B cells and associated with Epstein-Barr virus infection. A different subtype of AILD-TL? Leukemia. 2002;16:
10 43. Reichard KK, Schwartz EJ, Higgins JP, Narasimhan B, Warnke RA, Natkunam Y. CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells. Mod Pathol. 2006;19: Troxell ML, Schwartz EJ, van de Rijn M, et al. Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma. Appl Immunohistochem Mol Morphol. 2005;13: Weiss LM, Jaffe ES, Liu XF, Chen YY, Shibata D, Medeiros LJ. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood. 1992;79: Tan BT, Warnke RA, Arber DA. The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn. 2006;8: ; quiz Higgins JP, van de Rijn M, Jones CD, Zehnder JL, Warnke RA. Peripheral T-cell lymphoma complicated by a proliferation of large B cells. Am J Clin Pathol. 2000;114:
Mimics of Lymphoma in Routine Biopsies. Mixed follicular and paracortical hyperplasia. Types of Lymphoid Hyperplasia
Mimics of Lymphoma in Routine Biopsies Patrick Treseler, MD, PhD Professor of Pathology University of California San Francisco Types of Lymphoid Hyperplasia Follicular hyperplasia (B-cells) Paracortical
More informationMimics of Lymphoma in Routine Biopsies. I have nothing to disclose regarding the information to be reported in this talk.
Mimics of Lymphoma in Routine Biopsies Patrick Treseler, MD, PhD Professor of Pathology University of California San Francisco I have nothing to disclose regarding the information to be reported in this
More informationCase Report Nodular Lymphocyte-Predominant Hodgkin Lymphoma or T-cell/Histiocyte Rich Large B-cell Lymphoma: The Problem in Grey Zone Lymphomas
www.ijcep.com/ijcep708008 Case Report Nodular Lymphocyte-Predominant Hodgkin Lymphoma or T-cell/Histiocyte Rich Large B-cell Lymphoma: The Problem in Grey Zone Lymphomas Frank X. Zhao Department of Pathology,
More informationIncidence. Bimodal age incidence 15-40, >55 years Childhood form (0-14) more common in developing countries M:F=1.5:1; in all subtypes except NS
Hodgkin Lymphoma Hodgkin Lymphoma 30% of all lymphomas Absolute incidence unchanged Arise in lymph node, cervical region Neoplastic tissues usually contain a small number of tumor cells Incidence Bimodal
More informationCase Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent
Int J Clin Exp Med 2014;7(1):307-311 www.ijcem.com /ISSN:1940-5901/IJCEM1311029 Case Report A case of EBV positive diffuse large B-cell lymphoma of the adolescent Qilin Ao 2, Ying Wang 1, Sanpeng Xu 2,
More informationCase 3. Ann T. Moriarty,MD
Case 3 Ann T. Moriarty,MD Case 3 59 year old male with asymptomatic cervical lymphadenopathy. These images are from a fine needle biopsy of a left cervical lymph node. Image 1 Papanicolaou Stained smear,100x.
More informationHODGKIN LYMPHOMA DR. ALEJANDRA ZARATE OSORNO HOSPITAL ESPAÑOL DE MEXICO
HODGKIN LYMPHOMA DR. ALEJANDRA ZARATE OSORNO HOSPITAL ESPAÑOL DE MEXICO HODGKIN LYMPHOMA CLASSIFICATION Lukes & Butler Rye WHO-2016 Linphocytic and/or histiocytic Nodular & diffuse Nodular Sclerosis Lymphocyte
More informationNodular lymphocyte predominant Hodgkin lymphoma. Lymphoma Tumor Board. January 5, 2018
Nodular lymphocyte predominant Hodgkin lymphoma Lymphoma Tumor Board January 5, 2018 Etiology Subtypes of Classical Hodgkin Lymphoma (chl)* Nodular sclerosing HL Most common subtype Composed of large tumor
More information, , 2011 HODGKIN LYMPHOMA
European Federation of Cytology Societies 4tu Annual Tutorial in Cytopathology Trieste, June 6-10, 2011 HODGKIN LYMPHOMA Classification The World Health Organization Classification of Lymphomas (2001)
More informationECP meeting, Lisbon, september 2012 Slide seminar New and old challenges in the diagnosis of peripheral T-cell lymphomas
ECP meeting, Lisbon, september 2012 Slide seminar New and old challenges in the diagnosis of peripheral T-cell lymphomas Philippe Gaulard, Dept of Pathology, INSERM U955, Hôpital Henri Mondor, 94010 -
More information88-year-old Female with Lymphadenopathy. Faizi Ali, MD
88-year-old Female with Lymphadenopathy Faizi Ali, MD Clinical History A 88-year-old caucasian female presented to our hospital with the complaints of nausea, vomiting,diarrhea, shortness of breath and
More informationCase Report Nodular Lymphocyte Predominant Hodgkin Lymphoma versus T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Diagnostic Challenge
Case Reports in Pathology, Article ID 956217, 5 pages http://dx.doi.org/10.1155/2014/956217 Case Report Nodular Lymphocyte Predominant Hodgkin Lymphoma versus T-Cell/Histiocyte-Rich Large B-Cell Lymphoma:
More informationNon-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)
Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Lymphoid Neoplasms: 1- non-hodgkin lymphomas (NHLs) 2- Hodgkin lymphoma 3- plasma cell neoplasms Non-Hodgkin lymphomas (NHLs) Acute Lymphoblastic Leukemia/Lymphoma
More information11/8/2018 DISCLOSURES. I have NO Conflicts of Interest to Disclose. UTILTY OF DETECTING PATTERNS
Bharat N. Nathwani, M.D. City of Hope Medical Center Professor, Director of Pathology Consultation Services, 1500 East Duarte Road, Duarte, California, 91010 DISCLOSURES -------------------------------------------------------
More informationLymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC
Lymphoma: What You Need to Know Richard van der Jagt MD, FRCPC Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of lymphoma Conceptualizing
More informationImmunopathology of Lymphoma
Immunopathology of Lymphoma Noraidah Masir MBBCh, M.Med (Pathology), D.Phil. Department of Pathology Faculty of Medicine Universiti Kebangsaan Malaysia Lymphoma classification has been challenging to pathologists.
More informationLeukaemia Section Short Communication
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL INIST-CNRS Leukaemia Section Short Communication Classification of Hodgkin lymphoma over years Antonino Carbone, Annunziata
More informationThomas Hodgkin and Hodgkin lymphoma
J Hematopathol (2014) 7:123 138 DOI 10.1007/s12308-014-0214-3 REVIEW ARTICLE Thomas Hodgkin and Hodgkin lymphoma Judith A. Ferry Received: 26 June 2014 /Accepted: 31 July 2014 /Published online: 12 August
More informationPearls and pitfalls in interpretation of lymphoid lesions in needle biopsies
Pearls and pitfalls in interpretation of lymphoid lesions in needle biopsies Megan S. Lim MD PhD University of Pennsylvania October 8, 2018 Objectives To understand how the trend toward less invasive lymph
More informationDiffuse variant of lymphocyte-predominant Hodgkin lymphoma: a diagnostic challenge
J Hematopathol (2013) 6:145 150 DOI 10.1007/s12308-012-0162-8 CASE REPORT Diffuse variant of lymphocyte-predominant Hodgkin lymphoma: a diagnostic challenge Yuanming Zhang & Ihsane Ouansafi & Wayne Tam
More informationT cell lymphoma diagnostics and differential diagnosis to Hodgkin lymphoma
T cell lymphoma diagnostics and differential diagnosis to Hodgkin lymphoma Sylvia Hartmann Dr. Senckenberg Institute of Pathology Goethe University Frankfurt Overview Borderline ALCL classical HL Borderline
More informationFOLLICULARITY in LYMPHOMA
FOLLICULARITY in LYMPHOMA Reactive Follicular Hyperplasia Follicular Hyperplasia irregular follicles Follicular Hyperplasia dark and light zones Light Zone Dark Zone Follicular hyperplasia MIB1 Follicular
More information3/24/2017 DENDRITIC CELL NEOPLASMS: HISTOLOGY, IMMUNOHISTOCHEMISTRY, AND MOLECULAR GENETICS. Disclosure of Relevant Financial Relationships
DENDRITIC CELL NEOPLASMS: HISTOLOGY, IMMUNOHISTOCHEMISTRY, AND MOLECULAR GENETICS Jason L. Hornick, M.D., Ph.D. Director of Surgical Pathology and Immunohistochemistry Brigham and Women s Hospital Professor
More informationDifferential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital
Differential diagnosis of hematolymphoid tumors composed of medium-sized cells Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Lymphoma classification Lymphoma diagnosis starts with morphologic
More informationBiology, Clinical Course and Management of Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Biology, Clinical Course and Management of Nodular Lymphocyte-Predominant Hodgkin Lymphoma Lucia Nogová, Thomas Rudiger and Andreas Engert Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) differs
More informationFollicular Dendritic Cell Immunohistochemical Markers in Angioimmunoblastic T-Cell Lymphoma
RESEARCH ARTICLE Follicular Dendritic Cell Immunohistochemical Markers in Angioimmunoblastic T-Cell Lymphoma Megan L. Troxell, MD, PhD,* Erich J. Schwartz, MD, PhD,* Matt van de Rijn, MD, PhD,* Douglas
More informationMany of the hematolymphoid disorders are derived
REVIEW ARTICLE Practical Immunohistochemistry in Hematopathology: A Review of Useful Antibodies for Diagnosis Ji Lu, MD and Karen L. Chang, MD Abstract: This review article offers some useful panels of
More informationContents. vii. Preface... Acknowledgments... v xiii
Contents Preface... Acknowledgments... v xiii SECTION I 1. Introduction... 3 Knowledge-Based Diagnosis... 4 Systematic Examination of the Lymph Node... 7 Cell Type Identification... 9 Cell Size and Cellularity...
More informationHematopathology Specialty Conference Case #1
Hematopathology Specialty Conference Case #1 Robert (Bob) Ohgami, MD, PhD Assistant Professor Stanford University Disclosure of Relevant Financial Relationships Disclosure of Relevant Financial Relationships
More informationMantle Cell Lymphoma
HEMATOPATHOLOGY Original Article Mantle Cell Lymphoma Morphologic Findings in Bone Marrow Involvement JAY WASMAN, MD, 1 NANCY S. ROSENTHAL, MD,' AND DIANE C. FARHI, MD 2 Although mantle cell lymphoma (MCL),
More informationPrimary Cutaneous CD30-Positive T-cell Lymphoproliferative Disorders
Primary Cutaneous CD30-Positive T-cell Lymphoproliferative Disorders Definition A spectrum of related conditions originating from transformed or activated CD30-positive T-lymphocytes May coexist in individual
More informationBurkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8
Heme 8 Burkitt lymphoma Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8 Most common is t(8;14) Believed to be the fastest growing tumor in humans!!!! Morphology
More information7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour
7 Omar Abu Reesh Dr. Ahmad Mansour Dr. Ahmad Mansour -Leukemia: neoplastic leukocytes circulating in the peripheral bloodstream. -Lymphoma: a neoplastic process in the lymph nodes, spleen or other lymphatic
More informationShades of gray between large B-cell lymphomas and Hodgkin lymphomas: differential diagnosis and biological implications
& 2013 USCAP, Inc. All rights reserved 0893-3952/13 $32.00 S57 Shades of gray between large B-cell lymphomas and Hodgkin lymphomas: differential diagnosis and biological implications Nancy L Harris Department
More informationPrimary Spinal T-Cell Rich B-Cell Lymphoma: A Case Report
Primary Spinal T-Cell Rich B-Cell Lymphoma: A Case Report Pages with reference to book, From 148 To 149 Suhail Muzaffar,Irshad Nabi Soomro,Naila Kayani,Shahid Siddiqui ( Departments of Pathology, The Aga
More informationLymphoma Update: Lymphoma Update: What s Likely to be New in the New WHO. Patrick Treseler, MD, PhD University of California San Francisco
Lymphoma Update: What s Likely to be New in the New WHO Blood 127:2375; 2016 Patrick Treseler, MD, PhD University of California San Francisco Lymphoma Update: What IS New in the New WHO! Patrick Treseler,
More informationCase Report PAX5-Negative Classical Hodgkin Lymphoma: A Case Report of a Rare Entity and Review of the Literature
Hindawi Case Reports in Hematology Volume 2017, Article ID 7531729, 4 pages https://doi.org/10.1155/2017/7531729 Case Report PAX5-Negative Classical Hodgkin Lymphoma: A Case Report of a Rare Entity and
More informationLow-grade B-cell lymphoma
Low-grade B-cell lymphoma Patho-Basic 11. September 2018 Stephan Dirnhofer Pathology Outline Definition LPL, MBL/CLL/SLL, MCL FL Subtypes & variants Diagnosis including Grading Transformation Summary Be
More informationHodgkin Lymphomas: An Update
Hodgkin Lymphomas: An Update Roberto N. Miranda, M.D. Professor UT MD Anderson Cancer Center November 10 th, 2018 Disclosures Scientific Advisory Board, Allergan Inc, 2018 Hodgkin Lymphomas Classical Hodgkin
More informationVENTANA hematopathology solutions. Deliver diagnostic confidence
VENTANA hematopathology solutions Deliver diagnostic confidence 2 Hematopathology diagnostic solutions Contents VENTANA hematopathology assays 3 Detecting and subtyping hematological cancers 4 The importance
More informationPlasma cell myeloma (multiple myeloma)
Plasma cell myeloma (multiple myeloma) Common lymphoid neoplasm, present at old age (70 years average) Remember: plasma cells are terminally differentiated B-lymphocytes that produces antibodies. B-cells
More informationJKAU: Med. Sci., Vol. 14 No. 1, pp: 3-17 (2007 A.D. / 1428 A.H.) Composite Lymphoma
JKAU: Med. Sci., Vol. 14 No. 1, pp: 3-17 (2007 A.D. / 1428 A.H.) Composite Lymphoma Fadwa J. Altaf, FRCPC, F. I. A. C and Jaudah A. Al Maghrabi, FRCPC, FCAP Department of Pathology, Faculty of Medicine
More informationAngioimmunoblastic T-cell lymphoma
Unusual Presentation of Angioimmunoblastic T-cell Lymphoma as a Solitary Lymph Node N Ashalatha*, BN Kumarguru, BS Dayananda, AH Nagarajappa # Abstract Introduction: Angioimmunoblastic T-cell lymphoma
More informationHepatic Lymphoma Diagnosis An Algorithmic Approach
Hepatic Lymphoma Diagnosis An Algorithmic Approach Ryan M. Gill, M.D., Ph.D. University of California, San Francisco PLEASE TURN OFF YOUR CELL PHONES Disclosure of Relevant Financial Relationships USCAP
More informationComposite mantle cell and follicular lymphoma. A case report
Human Pathology (2009) 40, 259 263 www.elsevier.com/locate/humpath Case study Composite mantle cell and follicular lymphoma. A case report Raquel B. Ilgenfritz MD a,, Agnès Le Tourneau MD a, Michel Arborio
More informationDETERMINATION OF A LYMPHOID PROCESS
Chapter 2 Applications of Touch Preparation Cytology to Intraoperative Consultations: Lymph Nodes and Extranodal Tissues for Evaluation of Hematolymphoid Disorders INTRODUCTION As discussed in Chap. 1,
More informationVENTANA hematopathology solutions Comprehensive aids for detecting and subtyping
VENTANA hematopathology solutions Comprehensive aids for detecting and subtyping 1 12/4/2015 9:47:24 AM 2 Hematopathology diagnostic solutions Contents VENTANA hematopathology assays 3 Detecting and subtyping
More informationCharacteristic Histological Findings of Asymptomatic EBVassociated Lymphoproliferative Disorders in Tonsils
Journal of clinical and experimental hematopathology Vol. 58 No.3, 122-127, 2018 JC lin EH xp ematopathol Original Article Characteristic Histological Findings of Asymptomatic EBVassociated Lymphoproliferative
More informationLarge cell immunoblastic Diffuse histiocytic (DHL) Lymphoblastic lymphoma Diffuse lymphoblastic Small non cleaved cell Burkitt s Non- Burkitt s
Non Hodgkin s Lymphoma Introduction 6th most common cause of cancer death in United States. Increasing in incidence and mortality. Since 1970, the incidence of has almost doubled. Overview The types of
More informationAnaplastic Large Cell Lymphoma (of T cell lineage)
Anaplastic Large Cell Lymphoma (of T cell lineage) Definition T-cell lymphoma comprised of large cells with abundant cytoplasm and pleomorphic, often horseshoe-shaped nuclei CD30+ Most express cytotoxic
More informationB-cell lymphoma showing typical features of angioimmunoblastic T-cell lymphoma
B-cell lymphoma showing typical features of angioimmunoblastic T-cell lymphoma Masaki Mori, Yusuke Furukawa, Masaaki Takatoku, Tadashi Nagai, Kazuo Muroi, Keiya Ozawa Abstract We present a -year-old man
More informationMECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008
MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA April 16, 2008 FACULTY COPY GOAL: Learn the appearance of normal peripheral blood elements and lymph nodes. Recognize abnormal peripheral blood
More informationAggressive B-cell Lymphomas Updated WHO classification Elias Campo
Aggressive B-cell Lymphomas Updated WHO classification Elias Campo Hospital Clinic, University of Barcelona Diffuse Large B-cell Lymphoma A Heterogeneous Category Subtypes with differing: Histology and
More informationDefined lymphoma entities in the current WHO classification
Defined lymphoma entities in the current WHO classification Luca Mazzucchelli Istituto cantonale di patologia, Locarno Bellinzona, January 29-31, 2016 Evolution of lymphoma classification Rappaport Lukes
More informationCD5 Positive Follicular Lymphomas- A Diagnostic Dilemma in a Resource Restricted Laboratory Setting
Original Article DOI: 10.21276/APALM.1364 CD5 Positive Follicular Lymphomas- A Diagnostic Dilemma in a Resource Restricted Laboratory Setting Sakthi Sankari S 1 *, Arjunan A 2, Bhuvaneswari M.G. 2, Sindhuja
More information3/27/2017. Pulmonary Pathology Specialty Conference. Disclosure of Relevant Financial Relationships. Clinical History:
Pulmonary Pathology Specialty Conference Saul Suster, M.D. Medical College of Wisconsin Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position
More informationNON HODGKINS LYMPHOMA: INDOLENT Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary)
NON HODGKINS LYMPHOMA: INDOLENT Updated June 2015 by Dr. Manna (PGY-5 Medical Oncology Resident, University of Calgary) Reviewed by Dr. Michelle Geddes (Staff Hematologist, University of Calgary) and Dr.
More informationProtocol for the Examination of Specimens From Patients With Hodgkin Lymphoma*
Protocol for the Examination of Specimens From Patients With Hodgkin Lymphoma* Version: Hodgkin 3.1.0.1 Protocol Posting Date: October 2013 This protocol is NOT required for accreditation purposes *This
More informationUpdate on the Classification of Aggressive B-cell Lymphomas and Hodgkin Lymphoma
Update on the Classification of Aggressive B-cell Lymphomas and Hodgkin Lymphoma Nancy Lee Harris, M. D. Massachusetts General Hospital Harvard Medical School Aggressive B-cell Lymphomas WHO 4 th Edition
More informationExploring the Borderlands between Diffuse Large B-cell Lymphoma and Classical Hodgkin s Lymphoma
Exploring the Borderlands between Diffuse Large B-cell Lymphoma and Classical Hodgkin s Lymphoma Elaine S. Jaffe National Cancer Institute Bethesda, MD, USA On the Pathological Changes In Hodgkin s Disease
More information10/31/2017. Immunodeficiencies. Outline. Discuss EBV. Non-destructive Polymorphic Monomorphic Therapies Challenges
I have no financial disclosures Joo Y. Song, MD Assistant Professor of Clinical Pathology City of Hope National Medical Center Immunodeficiencies Outline Transplant Congenital Autoimmunity T-cell/immune
More informationExtramedullary precursor T-lymphoblastic transformation of CML at presentation
Extramedullary precursor T-lymphoblastic transformation of CML at presentation Neerja Vajpayee, Constance Stein, Bernard Poeisz & Robert E. Hutchison Clinical History 30 year old man presented to the emergency
More informationRituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial Bradley C. Ekstrand, Jennifer B. Lucas, Steven M. Horwitz, Zhen
More informationCerebellar EBV-associated diffuse large B cell lymphoma following angioimmunoblastic T cell lymphoma
J Hematopathol (2015) 8:235 241 DOI 10.1007/s12308-015-0241-8 CASE REPORT Cerebellar EBV-associated diffuse large B cell lymphoma following angioimmunoblastic T cell lymphoma Yi Zhou & Marc K. Rosenblum
More informationClassification of Hematologic Malignancies. Patricia Aoun MD MPH
Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences
More informationGastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR
Gastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR Pages with reference to book, From 305 To 307 Irshad N. Soomro,Samina Noorali,Syed Abdul Aziz,Suhail Muzaffar,Shahid
More information2012 by American Society of Hematology
2012 by American Society of Hematology Common Types of HIV-Associated Lymphomas DLBCL includes primary CNS lymphoma (PCNSL) Burkitt Lymphoma HIV-positive patients have a 60-200 fold increased incidence
More informationMolecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU
Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU Lecture outline Time 10:00 11:00 11:15 12:10 12:20 13:15 Content Introduction to lymphoma Review of lymphocyte biology
More informationDifferential cell counts in the histiocytic variant of lymphocytic predominance subtype of Hodgkin's
Journal of Clinical Pathology, 1978, 31, 1234-1238 Differential cell counts in the histiocytic variant of lymphocytic predominance subtype of Hodgkin's disease FIONA I. SUTHERLAND, J. B. MAcGILLIVRAY,
More informationAggressive B-cell Lymphomas
Neoplastic Hematopathology Update 2018 Aggressive B-cell Lymphomas Raju K. Pillai City of Hope National Medical Center I do not have any disclosures Disclosures Outline New entities and changes in WHO
More information11/2/2017. Immunodeficiencies. Joo Y. Song, MD Assistant Professor of Clinical Pathology. I have no financial disclosures.
I have no financial disclosures Joo Y. Song, MD Assistant Professor of Clinical Pathology City of Hope National Medical Center Immunodeficiencies Transplant Autoimmunity Drugs T-cell dysfunction (Age,
More informationT-cell/Histiocyte-Rich Large B-cell Lymphoma in Pediatric Patients: an Under-Recognized Entity?
Available online at www.annclinlabsci.org T-cell/Histiocyte-Rich Large B-cell Lymphoma in Pediatric Patients: an Under-Recognized Entity? Gabriela Gheorghe 1, Hemalatha G Rangarajan 2, Bruce Camitta 3,
More informationPathology of the Lymphoid System
Pathology of the Lymphoid System Learning Objectives: Define lymphadenitis and enumerate its types. Briefly describe the morphological appearance of reactive lymph node. Describe the microscopic picture
More informationA Unique Case of Nasal NK/T Cell Lymphoma with Frequent Remission and Relapse Showing Different Histological Features During 12 Years of Follow Up
J Clin Exp Hematopathol Vol. 50, No. 1, May 2010 Case Study A Unique Case of Nasal NK/T Cell Lymphoma with Frequent Remission and Relapse Showing Different Histological Features During 12 Years of Follow
More informationHemophagocytic Lymphohistiocytosis Secondary to T cell/histiocyte-rich Large B-cell Lymphoma
Hemophagocytic Lymphohistiocytosis Secondary to T cell/histiocyte-rich Large B-cell Lymphoma Katherine Devitt, M.D., Benjamin Chen, M.D., Ph.D., Hongbo Yu, M.D., Ph.D., Bruce Woda, M.D. 1 1 Department
More informationCase Report Follicular lymphoma mimicking marginal zone lymphoma in lymph node: a case report
Int J Clin Exp Pathol 2014;7(10):7076-7081 www.ijcep.com /ISSN:1936-2625/IJCEP0001940 Case Report Follicular lymphoma mimicking marginal zone lymphoma in lymph node: a case report Ikuo Matsuda 1, Yoshifumi
More informationComposite Angioimmunoblastic T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma A Case Report and Review of the Literature
Hematopathology / COMPOSITE T- AND B-CELL LYMPHOMA Composite Angioimmunoblastic T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma A Case Report and Review of the Literature Yin Xu, MD, PhD, 1 Robert W.
More informationCD30 expression utilization for the accuracy of classical Hodgkin s lymphoma staging
Romanian Journal of Morphology and Embryology 2006, 47(2):113 117 ORIGINAL PAPER CD30 expression utilization for the accuracy of classical Hodgkin s lymphoma staging CORINA FLANGEA 1), ELENA POTENCZ 2),
More informationHyperplasia of Mantle/Marginal Zone B Cells With Clear Cytoplasm in Peripheral Lymph Nodes A Clinicopathologic Study of 35 Cases
Hematopathology / HYPERPLASIA OF MANTLE/MARGINAL ZONE B CELLS WITH CLEAR CYTOPLASM Hyperplasia of Mantle/Marginal Zone B Cells With Clear Cytoplasm in Peripheral Lymph Nodes A Clinicopathologic Study of
More informationLymphocyte Predominant Hodgkin s Lymphoma. Case Presentation. How would you treat the patient?
Lymphocyte Predominant Hodgkin s Lymphoma Wei Ai, MD, PhD Assistant Clinical Professor University of California, San Francisco January 2010 Case Presentation 32 yo male, diagnosed with stage IIIA lymphocyte
More informationLymphoma Read with the experts
Lymphoma Read with the experts Marc Seltzer, MD Associate Professor of Radiology Geisel School of Medicine at Dartmouth Director, PET-CT Course American College of Radiology Learning Objectives Recognize
More informationAggressive B-Cell Lymphomas
Aggressive B-cell Lymphomas Aggressive B-Cell Lymphomas Stephen Hamilton Dutoit Institute of Pathology Aarhus Kommunehospital B-lymphoblastic lymphoma Diffuse large cell lymphoma, NOS T-cell / histiocyte-rich;
More informationDoes the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
Histopathology 2012, 61, 1214 1218. DOI: 10.1111/j.1365-2559.2012.04351.x SHORT REPORT Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
More informationLách
Lách Lách Lách Lách Splenogonadal fusion. Splenic tissue is attached to testicular tissue. Pseudocyst (false or secondary cyst). A, Outer aspect. Pseudocyst (false or secondary cyst). B, Inner surface.
More informationPathology of the indolent B-cell lymphomas Elias Campo
Pathology of the indolent B-cell lymphomas Elias Campo Hospital Clinic, University of Barcelona Small B-cell lymphomas Antigen selection NAIVE -B LYMPHOCYTE MEMORY B-CELL MCL FL LPL MZL CLL Small cell
More informationPathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e
Pathology #07 Mature B-Cell Neoplasm Hussein Al-Sa di Dr. Sohaib Al-Khatib 0 P a g e Thursday 18/2/2016 Our lecture today (with the next 2 lectures) will be about lymphoid tumors This is a little bit long
More informationLYMPHOMAS an overview of some subtypes of NHLs
One of the confusing aspects of the lymphoid neoplasms concerns the use of the descriptive terms "leukemia" and "lymphoma." LYMPHOMAS an overview of some subtypes of NHLs Leukemia is used for lymphoid
More informationLymphoma Series: Variants of Large-Cell Lymphoma
This material is protected by U.S. Copyright law. Unauthorized reproduction is prohibited. For reprints contact: Reprints@AlphaMedPress.com Lymphoma Series: Variants of Large-Cell Lymphoma T-Cell/Histiocyte-Rich
More informationLEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University
LEUKAEMIA and LYMPHOMA Dr Mubarak Abdelrahman Assistant Professor Jazan University OBJECTIVES Identify etiology and epidemiology for leukemia and lymphoma. Discuss common types of leukemia. Distinguish
More informationGray Zones and Double Hits Distinguishing True Burkitt Lymphoma from Other High-Grade B-NHLs Burkitt Lymphoma Burkitt-Like Lymphoma DLBCL Patrick Tres
Gray Zones and Double Hits Distinguishing True Burkitt Lymphoma from Other High-Grade B-NHLs Burkitt Lymphoma Burkitt-Like Lymphoma DLBCL Patrick Treseler, MD, PhD University of California San Francisco
More information3.1 Introduction. It is emphasised that not all tests are necessarily required in every case. 3.2 Taxonomic structure
CHAPTER 3 CLASSIFICATION 3.1 Introduction Accurate diagnosis underpins lymphoma management. Historically, competing lymphoma classifications have been a source of frustration to pathologists, clinicians
More informationHodgkin s lymphoma: the pathologist s viewpoint
162 REVIEW Hodgkin s lymphoma: the pathologist s viewpoint S A Pileri, S Ascani, L Leoncini, E Sabattini, P L Zinzani, P P Piccaluga, A Pileri Jr, M Giunti, B Falini, G B Bolis, H Stein... Despite its
More informationFrom Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport
From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology Songlin Zhang, MD, PhD LSUHSC-Shreveport I have no Conflict of Interest. FNA on Lymphoproliferative
More informationLYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center
LYMPHOMA Joginder Singh, MD Medical Oncologist, Mercy Cancer Center Lymphoma is cancer of the lymphatic system. The lymphatic system is made up of organs all over the body that make up and store cells
More informationCase Report Angioimmunoblastic T-Cell Lymphoma: A Questionable Association with Follicular Dendritic Cell Sarcoma
Hindawi Case Reports in Hematology Volume 2017, Article ID 9601094, 4 pages https://doi.org/10.1155/2017/9601094 Case Report Angioimmunoblastic T-Cell Lymphoma: A Questionable Association with Follicular
More informationUnknown Case 6. Ann T. Moriarty, MD
Unknown Case 6 Ann T. Moriarty, MD Unknown Case 6 61 year old male with an enlarged cervical lymph node. He has a history of lung carcinoma, renal cell carcinoma and lymphoma. Case 6 Image 1: Fine needle
More informationWorkshop Case # 8 (H 4205/07)
Workshop Case # 8 (H 4205/07) 53 y old male patient had a history of gastrectomy 15 years earlier for gastric carcinoma.on routine sonographic and CT control an enlarged lymph node was detected in the
More informationHENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Parts 2 and 3
HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD Parts 2 and 3 NEOPLASTIC LYMPHOID DISEASES Introduction o The bone marrow is the source of all cells in the
More information3/23/2017. Disclosure of Relevant Financial Relationships. Pitfalls in Immunohistochemistry in Hematopathology: CD20 and CD3 Can Let Me Down?!
Pitfalls in Immunohistochemistry in Hematopathology: CD20 and CD3 Can Let Me Down?! Judith A. Ferry Massachusetts General Hospital Disclosure of Relevant Financial Relationships USCAP requires that all
More informationEQA SCHEME CIRCULATION 33 EDUCATIONAL SLIDES DR GRAEME SMITH MONKLANDS DGH
EQA SCHEME CIRCULATION 33 EDUCATIONAL SLIDES DR GRAEME SMITH MONKLANDS DGH CASE E1 M: 68 yrs Left destructive sinonasal lesion.?lymphoma?adenocarcinoma CD20 CD10 BCL6 MIB1 Answers Diffuse large B cell
More information